Back to News
Market Impact: 0.35
Novo Nordisk Q3 Adj. Operating Profit Increases, Obesity Sales Up 22%; Raises 2026 Outlook
Source: Nasdaq
Corporate EarningsHealthcare & BiotechCompany Fundamentals
Novo Nordisk reported third-quarter net profit of 16.74 billion Danish kroner, down 16% year over year, and EPS/ADR of 3.79 kroner, also down 16%. Adjusted net profit fell 12% to 25.60 billion kroner; the supplied article text ends before further results or outlook details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.35
Ticker Sentiment
NVO-0.50
More News
- European shares jump over 1% after Democrats sweep US Congress, Novo Nordisk surges
- Novo CEO Doustdar 'Very Optimistic' About CagriSema
- Novo Nordisk ADR earnings missed by $3.74, revenue fell short of estimates
- Stocks making the biggest moves midday: CoreWeave, Micron, Booking Holdings, McDonald's, CVS Health & more
- European shares gain on Novo’s results; markets weigh U.S. midterms
- Stocks making the biggest moves premarket: Trump Media, Tesla, CoreWeave, Novo Nordisk and more